Menu
Go to Home
Stories & Media
The Captable
SMB Story
HerStory
SocialStory
Enterprise Story
The Decrypting Story
YS Life
YS Hindi
YS Tamil
YS TV
Videos
Discover
Companies
Startup Spotlight
Knowledge Base
Business Resources
Glossary
Everything AI
How To’s
Opinion
Press Release
Events
All Events
TechSparks '24
More
Pitch to us
Partner with us
My Story
Research
Stories
Your Story
SMBStory
HerStory
SocialStory
Enterprise Story
The Decrypting Story
YS Gulf
YS Life
YS Hindi
YS Tamil
The Captable
YS TV
Companies
Browse Startups
List your Startups
TechSparks '24
YS हिन्दी
Pitch To Us
Drugs Controller General of India (DCGI)
1st Jul 2021
Govt panel recommends against allowing SII to conduct Covovax trial on children aged 2-17 yrs
Helpdesk for Coronavirus
Remove
29th Jun 2021
Cipla gets DCGI nod to import Moderna's COVID-19 vaccine for restricted emergency use in India
Helpdesk for Coronavirus
Remove
22nd Jun 2021
IIT-B scientist gets DCGI nod to launch algo-based COVID-19 testing tool
Helpdesk for Coronavirus
Remove
17th May 2021
Govt releases first batch of anti-COVID drug 2-DG developed by DRDO, Dr Reddy's
Helpdesk for Coronavirus
Remove
8th May 2021
DCGI approves anti-COVID drug 2-DG developed by DRDO for emergency use
Helpdesk for Coronavirus
Remove
4th Jan 2021
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for COVID-19 vaccine
Helpdesk for Coronavirus
Remove
4th Jan 2021
Approval to vaccines 'turning point' in India's fight against COVID-19: Niti Aayog
Helpdesk for Coronavirus
Remove
4th Dec 2020
COVID-19: Zydus Cadila gets DGCI nod for Phase III clinical trials with biological therapy
Helpdesk for Coronavirus
Remove
24th Nov 2020
Hopefully DCGI will give EUA for Oxford's vaccine immediately after MHRA nod, says Biocon's Kiran Mazumdar-Shaw
Healthcare
Remove
6th Jul 2020
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial to treat COVID-19
Helpdesk for Coronavirus
Remove
21st Jun 2020
Glenmark launches COVID-19 drug FabiFlu at Rs 103 per tablet after DCGI nod
Helpdesk for Coronavirus
Remove
21st Jun 2016
A nascent Indian e-pharma sector already plagued by bias and harassment
Research
Remove